Medication and Fluid Management of Pediatric Sepsis and Septic Shock

Lauren Burgunder1, Caroline Heyrend2, Jared Olson2,3

  • 1Division of Pediatric Critical Care, Department of Pediatrics, Primary Children's Hospital, University of Utah, 100 North Mario Capecchi Drive, Salt Lake City, UT, 84113, USA.

Paediatric Drugs
|March 21, 2022
PubMed

Insights

Early recognition and rapid intervention are crucial for treating pediatric sepsis and septic shock. This review covers best practices for fluid resuscitation, antibiotics, and vasoactive medications, addressing ongoing controversies in treatment.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Pharmacology

Background:

  • Sepsis is a major global cause of death in neonates and children.
  • Effective management requires early recognition, fluid resuscitation, and antibiotics.
  • Current guidelines address initial management but controversies persist regarding optimal strategies.

Purpose of the Study:

  • To review current recommendations for medication and fluid management in pediatric sepsis and septic shock.
  • To highlight key issues in antibiotic selection, fluid resuscitation, and vasoactive/inotropic agent use.
  • To discuss controversies and ongoing research in adjunctive therapies.

Main Methods:

  • Review of international guidelines for pediatric sepsis and septic shock management.
  • Analysis of primary literature on fluid and medication interventions.
  • Discussion of current clinical trials and therapeutic nuances.

Main Results:

  • Best practice recommendations for fluid resuscitation, antibiotics, and vasoactive/inotropic agents are presented.
  • Key areas of controversy include fluid volume/type, antibiotic spectrum, and adjunctive therapies (e.g., vitamin C, steroids).
  • Emphasis on antimicrobial stewardship and tailoring antibiotic choices to local epidemiology.

Conclusions:

  • Optimal management of pediatric sepsis and septic shock involves a multifaceted approach.
  • Further research is needed to resolve controversies regarding fluid resuscitation and adjunctive therapies.
  • Adherence to evidence-based guidelines and antimicrobial stewardship is essential for improving outcomes.

Related Concept Videos

Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
86
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
60
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
95
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
45
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
476
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
61